Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by JeremyBauherkon Dec 14, 2018 12:42pm
189 Views
Post# 29116605

So you think HUGE at .30 down 64 cents is an opportunity?

So you think HUGE at .30 down 64 cents is an opportunity?Many said the same thing about investors that missed buying ISOL's 10, 30, 50, 70 cent lows. After collapsing from its 2.14 high to 80, 50, 30 cents, they reminded potential investors that they now had another shot at it. Soon after the collapse to 30 cents, ISOL had a R/S to $3. Last week ISOL again collapsed to $1.03. Investors enticed to buy at 30 cents now found themselves with a stock worth 10 cents pre R/S. Although ISOL had a formidable double from 1.03 to 2.30 this week, it is still very much a predicament for those in at 30, 50, 80 cents. So who's to say HUGE won't be a better, safer buy at .10 weeks or months from now? Who's to say HUGE doesn't perform a R/S from 30 cents to $3, suggested as a possibility by HUGE mgmt this week?  And with nothing to sustain the R/S price, who's to say it won't collapse to $1 as well? HUGE, along with dozens upon dozens of other cannabis stocks seemingly no more than hype induced during the cannabis frenzy, was not able to get a tight hold of its highs during its glory days. The collapse to 30 cents and/or lower, is quite possibly a natural return to order. A stock that has devastated investors that bought the highs does not necessarily become attractive once again, especially with no guarantee from anyone, including company mgmt, that the bottom is in. When faced with endless debacles, the only opportunity that persists time and time again, when it comes to penny stocks, is in buying the crashes and selling soon after for the often recurring 30-50%+ rebounds. I was happy to hold HUGE on its way to its 52- week highs. Nothing about HUGE since then makes me fee safe doing so any longer. Not even the impending sales licence, which has done nothing for a half dozen other cannabis stocks that recently got theirs. 
Bullboard Posts